Myo‐Inositol Levels in the Dorsal Anterior Cingulate Cortex Are Associated With Anxiety‐to‐Eat in Anorexia Nervosa

While substantial research has focused on general anxiety in anorexia nervosa (AN), eating-related anxiety is insufficiently understood and less is known about its underlying neurobiological mechanisms. We integrated behavioral and magnetic resonance spectroscopy (MRS) methods to characterize anxiety-to-eat and to identify its neurometabolic correlates in females with AN (n = 16) and in healthy weight females without a lifetime history of an eating disorder (healthy controls; HC; n = 16). Anxiety-to-eat was assessed via a computer-based task in which participants rated their level of anxiety-to-eat on a visual analogue scale in response to images of a standard serving of higher (HED) and lower energy density (LED) foods. Levels of nine neurometabolites in the dorsal anterior cingulate cortex (dACC), a brain region putatively involved in modulating anxiety-related responses, were assessed using edited MRS. The AN group reported greater anxiety-to-eat in response to HED and LED foods relative to the HC group. Both groups reported greater anxiety-to-eat in response to HED relative to LED foods. The neurometabolite myo-inositol (myo-I), a carbocyclic sugar and precursor molecule to phosphatidyl-inositol species in second-messenger systems shown to be dysregulated in AN (e.g., adrenergic, serotonergic, glutamatergic), was lower in the dACC in AN relative to HC. Additionally, in the AN group only, myo-I levels negatively predicted anxiety-to-eat in response to HED but not LED foods independent of body mass index, duration of illness, and general anxiety. These findings raise the possibility that lower myo-I in the dACC and its relationship with anxiety-to-eat responses in AN reflect a distinct biological and behavioral phenotype of AN pathology. To understand the clinical implications of these findings, future studies should investigate the effect of treatment on myo-I levels or directly manipulate myo-I levels in the diet and assess resulting changes in anxiety-to-eat.

Authors

Institutions

Publication Details

Journal
International Journal of Eating Disorders
Published
2025-10-14
DOI
https://doi.org/10.1002/eat.24549
Primary Topic
Eating Disorders and Behaviors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Myo‐Inositol Levels in the Dorsal Anterior Cingulate Cortex Are Associated With Anxiety‐to‐Eat in Anorexia Nervosa

Ángela S. Guarda, Richard A.E. Edden, Kimberly Smith, Yulu Song et al.
International Journal of Eating Disorders
Eating Disorders and Behaviors
article

Myo‐Inositol Levels in the Dorsal Anterior Cingulate Cortex Are Associated With Anxiety‐to‐Eat in Anorexia Nervosa

Ángela S. Guarda, Richard A.E. Edden, Kimberly Smith, Yulu Song, Christopher W. Davies‐Jenkins, Sarah H. Guo
article en

Abstract

While substantial research has focused on general anxiety in anorexia nervosa (AN), eating-related anxiety is insufficiently understood and less is known about its underlying neurobiological mechanisms. We integrated behavioral and magnetic resonance spectroscopy (MRS) methods to characterize anxiety-to-eat and to identify its neurometabolic correlates in females with AN (n = 16) and in healthy weight females without a lifetime history of an eating disorder (healthy controls; HC; n = 16). Anxiety-to-eat was assessed via a computer-based task in which participants rated their level of anxiety-to-eat on a visual analogue scale in response to images of a standard serving of higher (HED) and lower energy density (LED) foods. Levels of nine neurometabolites in the dorsal anterior cingulate cortex (dACC), a brain region putatively involved in modulating anxiety-related responses, were assessed using edited MRS. The AN group reported greater anxiety-to-eat in response to HED and LED foods relative to the HC group. Both groups reported greater anxiety-to-eat in response to HED relative to LED foods. The neurometabolite myo-inositol (myo-I), a carbocyclic sugar and precursor molecule to phosphatidyl-inositol species in second-messenger systems shown to be dysregulated in AN (e.g., adrenergic, serotonergic, glutamatergic), was lower in the dACC in AN relative to HC. Additionally, in the AN group only, myo-I levels negatively predicted anxiety-to-eat in response to HED but not LED foods independent of body mass index, duration of illness, and general anxiety. These findings raise the possibility that lower myo-I in the dACC and its relationship with anxiety-to-eat responses in AN reflect a distinct biological and behavioral phenotype of AN pathology. To understand the clinical implications of these findings, future studies should investigate the effect of treatment on myo-I levels or directly manipulate myo-I levels in the diet and assess resulting changes in anxiety-to-eat.

International Journal of Eating DisordersVol. 59(1)
Kennedy Krieger Institute (US), Johns Hopkins University (US), Johns Hopkins Medicine (US)
Openalex Percentile: Top 59%
Eating Disorders and Behaviors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.